Creator: Dr. Tran Le, MD, DABOM
Published: 2026-07-16T14:55:20+00:00

If you've started a GLP-1 and noticed your smartwatch resting heart rate creeping up a few points, you're not imagining it, and you're not alone. It's a very common question we field in our practice. The short answer: yes, GLP-1 medications tend to nudge resting heart rate up by a small amount, and for most people that change is modest and not dangerous. But it's worth understanding why it happens, what the numbers actually are, and the specific signs that should prompt a call.

This isn't medical advice for your individual situation, but it's the same explanation we give patients across Texas and Utah when they ask.

Do GLP-1 medications raise your heart rate?

Yes. A small rise in resting heart rate is what clinicians call a class effect. A modest increase in resting heart rate is a class effect of GLP-1 receptor agonists. It occurs with all medications in this category. Across the major diabetes and weight-management trial programs, modest increases in resting heart rate consistently appear across GLP-1 trials, typically averaging 2 to 4 beats per minute.

To put that in perspective, a couple of beats per minute is a smaller change than what you'd get from a cup of coffee or climbing a flight of stairs. For semaglutide specifically, trials have documented mean increases in roughly that same 2–4 bpm range. Tirzepatide is the dual GIP/GLP-1 medication. It behaves similarly: clinical trials show tirzepatide can cause modest increases in resting heart rate, typically 2-4 beats per minute above baseline.

One important nuance: these are averages. Individual responses vary quite a bit. In our practice, some patients see no measurable change at all, while a smaller subset notice a more noticeable bump. That range is well described in the trial data, where a minority of participants experience larger increases while most cluster around the small average.

Why does this happen? The mechanism

There are two leading explanations, and they probably work together.

The first is a direct effect on the heart's natural pacemaker. Your heartbeat is set by the sinoatrial (SA) node, and GLP-1 receptors live right there. Research in isolated hearts has shown that GLP-1 administration shortened the action potential cycle length of pacemaker cells and shifted the site of earliest activation. The effect was independent of HCN blockade. Collectively, these data support a direct effect of GLP-1 on GLP-1 receptors within the heart. In other words, the medication can speak directly to the cells that time your pulse.

The second involves the autonomic nervous system. This is the automatic wiring that balances your "gas pedal" (sympathetic) and "brake" (parasympathetic) signals. GLP-1 receptors are present in areas of the brain that regulate autonomic function, including heart rate control. Activation of these receptors may influence the balance between sympathetic (stimulatory) and parasympathetic (inhibitory) nervous system activity. Some research suggests that GLP-1 receptor agonists may increase sympathetic tone or decrease parasympathetic activity, which could lead to a modest elevation in resting heart rate.

Interestingly, the heart-rate effect doesn't climb endlessly as your dose goes up. In tirzepatide trials the dose-response curve is shallow. The jump early in titration accounts for most of the change, while higher doses add very little on top. That fits with the idea that the effect is driven by receptor occupancy that saturates fairly early rather than by dose-proportional pharmacology.

The increase also tends to show up early. The heart rate increase usually occurs within the first few weeks of treatment and tends to persist while on the medication. That's part of why we start low and go slow with dosing. It gives your body time to adjust.

Does a higher heart rate mean GLP-1s are bad for your heart?

This is the part that surprises people. Despite the small bump in pulse, the large cardiovascular outcome trials point in a reassuring direction. As one clinical review put it, one of the most reassuring findings is that cardiovascular outcome data remain strongly favorable despite small increases in resting heart rate. Large randomized trials evaluating liraglutide, semaglutide, and dulaglutide consistently demonstrate reductions in major adverse cardiovascular events, including myocardial infarction, stroke, and cardiovascular death. If a modest rise in heart rate were clinically harmful, outcome trials would likely show increased event rates.

The landmark example is the SELECT trial. In a large study of adults with overweight or obesity and established heart disease, but without diabetes, MACE occurred in 6.5% of semaglutide-treated participants vs 8.0% on placebo (hazard ratio 0.80, 95% CI 0.72-0.90, p<0.001). That is a 20% relative risk reduction. Those are population-level research findings for a specific brand-name dose. They are not a promise about any individual's outcome, but they explain why the small heart-rate change hasn't alarmed cardiologists.

What's a normal heart rate, and when should you worry?

For context, a normal resting heart rate ranges from 60 to 100 beats per minute for adults. A resting rate consistently above 100 has a name, tachycardia. As Cleveland Clinic describes it, tachycardia is an abnormal heart rhythm with a fast heart rate of more than 100 beats per minute at rest. It can range from mild to life-threatening.

So when should a GLP-1 patient reach out? Mayo Clinic's guidance is a good rule of thumb: talk with your healthcare professional if your resting heart rate is regularly above 100 beats per minute. Also, talk with your health professional if you're not a trained athlete and your resting heart rate is often below 60 beats per minute. It's especially important to see a healthcare professional if you also have symptoms such as fainting, dizziness or shortness of breath.

In our practice, we ask patients to loop us in if they notice a persistently elevated resting pulse, new palpitations, chest discomfort, lightheadedness, or unusual fatigue. Practical steps that help: stay well hydrated (dehydration can raise your pulse on its own), taper caffeine and alcohol if they're high, and don't rush your titration. If you have a known arrhythmia or heart condition, that's a conversation to have before starting. The FDA labels for these medications recommend heart-rate monitoring, and it's a routine part of a well-run physician-led program.

Frequently asked questions

Will the heart-rate increase go away if I keep taking my GLP-1?

For most people it's a small, stable change rather than something that keeps climbing. In the trials it appears early and then tends to hold steady rather than worsening over time. If your pulse is climbing progressively or you feel symptoms, that's worth reporting rather than waiting it out.

Is one medication safer for my heart than another?

Both semaglutide and tirzepatide show similar, modest heart-rate effects, and both classes have strong cardiovascular safety data behind them. Which fits you best depends on your health history, tolerance, and goals. That's exactly what we sort out in a consult. You can compare our semaglutide and tirzepatide options, including brand-name Wegovy, Ozempic, Zepbound, and Mounjaro through our à la carte plan.

Should I track my heart rate on a smartwatch?

It's a reasonable habit, with a caveat: wearables aren't perfectly accurate, so use them to spot trends rather than to panic over a single high reading. The most reliable resting measurement is taken first thing in the morning before you get up.

Talk to a doctor who watches the details

A few extra beats per minute is usually nothing to fear, but usually isn't the same as always, which is why real medical oversight matters. Our practice is physician-led by Dr. Tran Le, MD, DABOM, triple board-certified in Obesity Medicine, Addiction Medicine, and Occupational and Environmental Medicine. We review your history, monitor how you respond, and adjust the plan around your body. It is not a one-size-fits-all protocol.

Curious whether a GLP-1 is a smart fit for you? Start your consultation here or take a look at our straightforward pricing. (Compounded medications are not FDA-approved and are prepared by licensed pharmacies.)

Do GLP-1 Medications Raise Your Heart Rate? A Doctor Explains